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Objective. Chronic knee pain is a major cause of disability and health care expenditure, but there are concerns about
efﬁcacy, cost, and side effects associated with usual primary care. Conservative rehabilitation may offer a safe, effective,
affordable alternative. We compared the effectiveness of a rehabilitation program integrating exercise, self-management,
and active coping strategies (Enabling Self-management and Coping with Arthritic Knee Pain through Exercise [ESCAPE-
knee pain]) with usual primary care in improving functioning in persons with chronic knee pain.
Methods. We conducted a single-blind, pragmatic, cluster randomized controlled trial. Participants age >50 years,
reporting knee pain for >6 months, were recruited from 54 inner-city primary care practices. Primary care practices were
randomized to continued usual primary care (i.e., whatever intervention a participant’s primary care physician deemed
appropriate), usual primary care plus the rehabilitation program delivered to individual participants, or usual primary
care plus the rehabilitation program delivered to groups of 8 participants. The primary outcome was self-reported
functioning (Western Ontario and McMaster Universities Osteoarthritis Index physical functioning [WOMAC-func]) 6
months after completing rehabilitation.
Results. A total of 418 participants were recruited; 76 (18%) withdrew, only 5 (1%) due to adverse events. Rehabilitated
participants had better functioning than participants continuing usual primary care (3.33 difference in WOMAC-func
score; 95% conﬁdence interval [95% CI] 5.88, 0.78; P  0.01). Improvements were similar whether participants
received individual rehabilitation (3.53; 95% CI 6.52, 0.55) or group rehabilitation (3.16; 95% CI 6.55, 0.12).
Conclusion. ESCAPE-knee pain provides a safe, relatively brief intervention for chronic knee pain that is equally
effective whether delivered to individuals or groups of participants.
KEY WORDS. Integrated rehabilitation; Knee pain.
INTRODUCTION
Chronic knee pain is regarded as a mundane, inevitable,
unmanageable consequence of aging. This overlooks the
suffering, physical disability (1–4), psychosocial distress
(5), health care expenditure (6–8), and socioeconomic bur-
den (9) caused by chronic knee pain, and its indirect role
through mobility and function impairment in the develop-
ment of common chronic comorbidities (hypertension, di-
abetes, etc.) (10).
Primary care physicians label chronic knee pain as os-
teoarthritis (OA) and prescribe medication to relieve pain
(1,11,12), but there are concerns about the safety (13,14),
efﬁcacy (15), and costs (16) of medication, particularly
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1211nonsteroidal antiinﬂammatory drugs (13,14). Furthermore,
palliative medication does not address functional impair-
ment (1–4). Improving function is best achieved if patients
experience the beneﬁts attainable from exercise (17–19)
and patient education/self-management interventions
(20–22). These interventions are usually delivered sepa-
rately, but self-management interventions that do not in-
clude a signiﬁcant exercise component are of limited value
(22,23). Combining exercise and self-management might
enhance their separate beneﬁts, but few people will beneﬁt
if this produces complex, unworkable rehabilitation pro-
grams. As more people live longer (24) and patterns of
incidence change (25), safe, effective, and efﬁcient inter-
ventions that improve functioning and can be delivered to
the large numbers of people will be needed.
We devised a brief rehabilitation program integrating a
simple, personalized, progressive exercise regimen with
patient education, self-management, and active coping
strategies: Enabling Self-management and Coping with
Arthritic Knee Pain through Exercise (ESCAPE-knee pain).
Our primary hypothesis was that participation in ESCAPE-
knee pain would improve functioning better than continu-
ing usual primary care. A subsidiary hypothesis was that
rehabilitation would be equally effective whether deliv-
ered to individuals or groups of people.
PATIENTS AND METHODS
Design. This pragmatic study compared usual primary
care with a rehabilitation program designed to improve
functioning using exercise, education, and self-manage-
ment strategies to alter behavior and dispel inappropriate
health beliefs according to a prespeciﬁed protocol. A prag-
matic trial is carried out in a clinical setting and evaluates
a feasible intervention for that setting using broad inclu-
sion criteria to recruit a representative sample of the ref-
erence population, with few exclusion criteria to avoid
maximizing the size of treatment effect by excluding indi-
viduals unlikely to beneﬁt.
A cluster randomized trial design was chosen to mini-
mize the risk of patients allocated to different arms ex-
changing information or primary care physicians altering
their usual care (26,27). Primary care practices were the
unit of randomization. The randomization list was gener-
ated at a central location away from the research center by
an author (BR), who was not involved in the execution of
the trial. Collaborating practices gave written consent for
investigators to identify potential participants from their
databases. Practices were randomly allocated in blocks of
3 to receive 1) usual primary care (whatever intervention a
participant’s primary care physician considered to be re-
quired and appropriate), 2) usual primary care plus indi-
vidual rehabilitation (Indiv-rehab), or 3) usual primary
care plus rehabilitation in groups of 8 participants (Grp-
rehab).
The study was carried out between August 2000 and
October 2004 in South East London, UK, after approval by
relevant local research ethics committees. All assessments
were conducted in the Rehabilitation Research Unit,
Dulwich Community Hospital and all rehabilitation ses-
sions performed in the Physiotherapy Out-patient De-
partment.
Study population. Broad inclusion criteria were adopted.
We recruited individuals age 50 years or older who had
consulted a primary care physician for mild, moderate, or
severe knee pain of 6 months’ duration. Many partici-
pants’ condition had been labeled OA based on their clin-
ical presentation and history without attempting to iden-
tify the cause of pain using investigations not routinely
available to primary care physicians (e.g., radiographs).
Exclusion criteria were as follows: lower limb arthro-
plasty, physiotherapy for knee pain in the preceding 12
months, intraarticular injections in the preceding 6
months, unstable medical conditions, inability/unwilling-
ness to exercise, wheelchair dependence, and inability to
understand English. Participants were not excluded if they
used assistive walking devices; had stable comorbidities
common in this age group (e.g., type II diabetes, cardio-
vascular or respiratory disorders); or had back, lower, or
upper limb pain.
The (cluster randomized) design meant potential partic-
ipants were given speciﬁc written information detailing
the intervention they would receive. Persons interested in
participating telephoned the investigators and received a
verbal explanation of the trial; eligibility criteria were
checked and a baseline assessment was arranged for those
who were eligible and willing. At this assessment, written
consent was obtained and a medical history taken. Man-
agement of all participants’ knee and coexistent medical
problems continued at the primary care physician’s dis-
cretion and was documented at all assessments.
Intervention. The rehabilitation program is outlined in
Appendix A (available at the Arthritis Care & Research
Web site at http://www.interscience.wiley.com/jpages/
0004-3591:1/suppmat/index.html) with a detailed de-
scription available at www.kcl.ac.uk/gppc/escape. The
content and format were identical for both Indiv-rehab and
Grp-rehab, involving 12 supervised sessions (twice weekly
for 6 weeks) that combined discussion on speciﬁc topics
regarding self-management and coping, etc., with an indi-
vidualized, progressive exercise regimen. To ensure con-
sistency in content and delivery, the same experienced
physiotherapist devised, supervised, and progressed all
sessions for all participants (NW).
Outcomes. The Likert version of the Western Ontario
and McMaster Universities Osteoarthritis Index (WOMAC)
was administered at each study visit. This questionnaire
produces a total score (WOMAC-total, 0–96 points), with
subscores for physical functioning (WOMAC-func, 0–68
points), pain (WOMAC-pain, 0–20 points), and stiffness
(0–8 points, data not reported) (28). The WOMAC was
completed by the participants. Lower WOMAC scores in-
dicate better health status.
Secondary outcomes were pain (WOMAC-pain), ob-
jective functional performance (aggregated functional per-
formance time of 4 common activities of daily living
[AFPT]) (29), exercise health beliefs and self-efﬁcacy ques-
1212 Hurley et altionnaire (ExBeliefs) (30), anxiety and depression (Hospi-
tal Anxiety and Depression Scale [HADS]) (31), self-re-
ported health status (EuroQol) (32) converted into quality-
adjusted life years based on utility weights collected in a
UK general population sample (33), condition-speciﬁc pa-
tient preference health-related quality of life questionnaire
(McMaster Toronto Arthritis [MACTAR]) (34), quadriceps
strength (quadriceps maximum voluntary contraction),
and quadriceps voluntary activation (29). Lower AFPT
and HADS values and higher values in other outcomes
indicate better health status. Assessment time was 45
minutes.
All outcomes were assessed at baseline, immediately
after completion of the intervention or recruitment to the
usual primary care arm (6-week assessment), and 6 months
after completion of rehabilitation or 7.5 months after re-
cruitment to the usual care arm, the prespeciﬁed primary
end point. The immediate effect of the intervention (6-
week assessment) on functioning is provided for compar-
ison with other studies.
Blinding. Outcome assessors were blinded to a partici-
pant’s allocation. Success of blinding was evaluated by
asking assessors to identify each participant’s allocation at
each assessment; if they identiﬁed rehabilitation they were
further asked to identify whether the participant had been
in the Indiv-rehab or Grp-rehab arm.
Attendance. Nonattendance at the supervised reha-
bilitation sessions was carefully recorded. Regardless of
the number of rehabilitation sessions attended, all par-
ticipants were invited to attend all assessments, or
complete the outcome questionnaires by mail (n  7)
(Figure 1).
Figure 1. Flowchart of recruitment and retention of primary care practices and trial participants.
GP  general practitioner.
Rehabilitation Program for Chronic Knee Pain 1213Sample size. Lack of cluster randomized trials of
chronic knee pain in primary care made sample size esti-
mation problematic. A clinically meaningful difference
was considered to be 15%. Based on the study by Bellamy
et al of persons with knee OA who had a mean  SD
baseline WOMAC-func score of 41.3  14.8 (28), we esti-
mated that individual randomization would require 150
participants per arm for a trial with 90% power to detect a
15% difference between trial arms, with a 5% signiﬁcance
level (2-tailed) and allowing for 20% withdrawal by 6
months. Using intracluster correlation coefﬁcients (ICCs)
observed in other studies of chronic conditions in primary
care (27), we inﬂated this sample size by 33% (i.e., a
design effect of 1.33; 200 participants per arm) to take into
account cluster randomization, and aimed to minimize the
design effect by recruiting as many clusters as possible to
decrease the average number of participants per cluster
(26,27).
Statistical analysis. Statistical analysis followed a pre-
speciﬁed protocol, based on intent-to-treat with no interim
or post hoc analyses. Statistical signiﬁcance was set at P
less than 0.05. Outcomes for the 3 trial arms are presented
as the mean  SD or median (range), and standardized
effect sizes (95% conﬁdence intervals [95% CIs]) were
calculated from the difference between the mean outcome
at 6 months for one group minus the mean outcome at 6
months for another divided by the SD of the mean out-
comes adjusted for baseline outcomes.
Because primary care practice characteristics did not
affect the results, and the interventions were applied to
individuals rather than primary care practices, demo-
graphic and clinical outcome variables are described for
individual participants. To adjust for correlations between
patients within a cluster, weighted t-tests or adjusted chi-
square tests were used to test for differences between arms
at baseline.
Multilevel modeling was used to estimate the group
means and differences in outcome effect of the rehabilita-
tion programs (using restricted iterative generalized least
squares estimation using Multilevel Modelling for Win-
dows, version 2.01, Institute of Education, London). Mul-
tilevel modeling was used to adjust for the intracluster
correlations (patients within a primary care practice are
likely to be more similar to one another than patients from
another primary care practice), which violates the assump-
tion of independence that is fundamental for the correct
application of many statistical procedures.
Likelihood ratio tests were used to test random effects
and Wald’s test was used to test ﬁxed parameters.
WOMAC-func scores were initially compared across all 3
treatment arms, then for usual care versus rehabilitation
(Indiv-rehab and Grp-rehab arms combined) and, pair-
wise, each arm versus each other arm, using baseline
WOMAC-func score as a covariate.
To estimate the effect of missing data, logistic regression
was used to identify predictors of withdrawal. A longitu-
dinal model was then constructed that jointly modeled the
outcome at 6 weeks and the outcome at 6 months, allowing
the outcome to be correlated for each participant. Vari-
ables associated with withdrawal were included in the
model, allowing the effect of these variables to be different
at 6 weeks and 6 months. This adjusts for the measured
characteristics of participants who withdrew being differ-
ent from those who remained in the trial. Missing data
were assumed to be missing at random.
Preplanned interaction tests were performed to investi-
gate whether treatment effects were inﬂuenced by anxiety
and depression (HADS) or exercise health beliefs and con-
ﬁdence in ability to exercise (ExBeliefs). First, a model was
ﬁtted to 6-month WOMAC-func with the covariates base-
line WOMAC-func, treatment group, and baseline HADS
depression, followed by a further model with an interac-
tion term of HADS depression with treatment group. This
procedure was repeated using HADS anxiety, ExBeliefs
total, and ExBeliefs self-efﬁcacy.
For all comparisons, both unadjusted (adjusting only for
the baseline covariate) and adjusted differences (adjusting
for other potential confounding factors) were estimated,
the latter as sensitivity analyses to explore the robustness
of the unadjusted analyses to confounding. Because ad-
justment did not alter the effect size estimates, only the
former are reported. Finally, the effect of unblinding, effect
of assessor, and compliance with treatment were included
in analyses to better interpret the effects of rehabilitation.
The number needed to treat (NNT; number of partici-
pants required to undertake rehabilitation so that 1 partic-
ipant reports meaningful improvement in functioning
[15%] 6 months after completion of rehabilitation) and
95% CI were calculated by comparing the proportion of
rehabilitated participants who achieved this improvement
compared with the proportion achieving the improvement
with usual care.
RESULTS
Recruitment and retention. A total of 76 primary care
practices were invited to collaborate; 22 declined or were
unable to take part. Searches of the databases of the 54
consenting practices identiﬁed 1,098 potentially eligible
participants who could be contacted. Of these, 186 (16%)
were ineligible, 381 (34%) uninterested, and 113 (12%)
unable to participate; 418 (38%) were recruited. The re-
cruitment and retention of practices and individuals is
shown in Figure 1. Although it was slightly more difﬁcult
to recruit participants into Grp-rehab, there was no evi-
dence of differential recruitment to trial arms and all base-
line characteristics were balanced (Table 1).
By 6 months, 76 (18%) participants had withdrawn (Fig-
ure 1). There was no evidence of differential attrition. Only
5 (1%) participants withdrew because of exercise-related
adverse events; 3 had exacerbation of pain (2 knee, 1 hip)
and 2 with cardiac pacemakers had concerns about exer-
cising, despite reassurance. No patient with outcome data
was excluded from the analysis.
Primary outcome. Mean baseline WOMAC-func was
27.2 (Table 2). Immediately after completing the program
(6-week assessment), functioning improved (usual care
1214 Hurley et alTable 2. Estimated mean outcome (95% conﬁdence intervals) at 6 months for usual
primary care and rehabilitation groups, adjusting for baseline values*
Outcome
Baseline mean
(n  418)†
Outcome at 6 months
Usual primary care
(n  113)
Rehabilitation
(n  229)‡
Primary outcome
WOMAC-function 27.2 (25.7, 28.6) 25.0 (22.9, 27.1) 21.6 (20.2, 23.1)
Secondary outcomes
WOMAC-pain 7.6 (7.2, 8.0) 6.7 (6.1, 7.4) 5.7 (5.3, 6.2)
WOMAC-total 38.4 (36.5, 40.3) 35.0 (32.0, 38.0) 30.4 (28.3, 32.6)
AFPT, seconds 63.3 (59.8, 66.7) 61.0 (57.2, 64.9) 57.6 (54.9, 60.2)
ExBeliefs self-efﬁcacy 13.8 (13.5, 14.1) 14.0 (13.4, 14.6) 15.3 (14.9, 15.7)
ExBeliefs total 64.2 (63.5, 65.0) 64.0 (62.7, 65.3) 67.5 (66.6, 68.5)
HADS anxiety 6.53 (6.11, 6.95) 5.97 (5.46, 6.49) 5.32 (4.96, 5.68)
HADS depression 4.86 (4.53, 5.20) 4.28 (3.87, 4.69) 3.93 (3.64, 4.22)
MACTAR 31.6 (31.1, 32.1) 41.8 (40.3, 43.3) 44.0 (42.9, 45.0)
EQ-5D 0.60 (0.57, 0.63) 0.66 (0.60, 0.71) 0.64 (0.61, 0.68)
Right QMVC, newtons 227.8 (216.5, 239.2) 230.2 (217.7, 242.7) 237.4 (228.8, 246.0)
Right QVA, % 71.0 (68.3, 73.6) 68.3 (61.8, 74.8) 74.7 (70.1, 79.4)
Left QMVC, newtons 203.4 (193.5, 213.6) 203.0 (187.6, 218.3) 210.8 (199.7, 221.9)
Left QVA, % 72.5 (70.0, 75.0) 70.6 (66.2, 75.0) 76.3 (73.3, 79.4)
* Estimates represent the predicted outcome for a participant with average baseline WOMAC-function,
i.e., baseline WOMAC-function was centered around the mean before inclusion in the model. See Table
1 for deﬁnitions.
† Data from all participants.
‡ Number of participants analyzed for primary outcome for the individual and group rehabilitation arms
are combined. The number analyzed for secondary outcomes was not always the same because a few data
were missing for some outcomes.
Table 1. Participant characteristics and mean baseline values for outcomes*
Variable Usual care Indiv-rehab Grp-rehab
Sex, female:male 96:44 104:42 94:38
Age, mean (range) years 67 (51–89) 66 (50–91) 68 (51–84)
Duration of symptoms,
median (IQR) years
6 (3–15) 7 (3–15) 5 (2.5–11)
Height, mean (range) meters 1.65 (1.46–1.89) 1.64 (1.45–1.97) 1.63 (1.39–1.92)
Body mass, mean (range) kg 81.8 (48–135) 80.6 (47–118) 80.2 (54–139)
Body mass index, mean
(range) kg/m
2
30.3 (20–51) 30.0 (18–45) 30.18 (20–50)
WOMAC-function 27.2  14.6 26.4  14.7 27.9  14.7
WOMAC-pain 7.7  4.0 7.4  4.0 7.69  4.1
WOMAC-total 38.6  19.6 37.5  19.4 39.1  19.7
AFPT, seconds 66.0  39.4 58.5  29.9 65.7  35.7
ExBeliefs self-efﬁcacy 13.5  3.5 14.1  3.4 13.7  3.2
ExBeliefs total 64.0  7.7 65.0  8.1 63.7  7.7
HADS anxiety 6.7  4.6 6.3  3.9 6.6  4.5
HADS depression 5.1  3.7 4.5  3.2 5.0  3.4
MACTAR 31.6  5.1 31.9  5.0 31.2  5.3
EQ-5D 0.60  0.32 0.59  0.28 0.60  0.30
Right QMVC, newtons 238.4  115 229.8  102 214.7  107
Right QVA, % 72.2  23.6 71.1  24.4 69.9  25.6
Left QMVC, newtons 212.0  106 202.2  89 195.7  95
Left QVA, % 71.9  24.3 72.8  24.4 72.9  22.1
* Values are the mean  SD unless otherwise indicated. Indiv-rehab  individual rehabilitation; Grp-
rehab  group rehabilitation; IQR  interquartile range; WOMAC  Western Ontario and McMaster
Universities Osteoarthritis Index; WOMAC-function  WOMAC function subscale; WOMAC-pain 
WOMAC pain subscale; WOMAC-total  total score; AFPT  aggregate function performance time;
ExBeliefs self-efﬁcacy  exercise health beliefs self-efﬁcacy subscale; ExBeliefs total  exercise health
beliefs total score; HADS anxiety  Hospital Anxiety and Depression Scale anxiety subscale; HADS
depression  Hospital Anxiety and Depression Scale depression subscale; MACTAR  McMasters
Toronto Arthritis questionnaire; EQ-5D  EuroQol generic assessment of health status; QMVC  quad-
riceps maximum voluntary contraction; QVA  quadriceps voluntary activation.
Rehabilitation Program for Chronic Knee Pain 121525.9, 95% CI 23.4, 28.3; rehabilitation 20.0, 95% CI 18.3,
21.7; Indiv-rehab 19.8, 95% CI 17.6, 22.0; Grp-rehab 20.2,
95% CI 17.6, 22.9). At the primary end point, 6 months
after completing the program, some of these improvements
had been lost but WOMAC-func differed signiﬁcantly
across the 3 arms (joint Wald’s test, P  0.04). WOMAC-
func was better following rehabilitation compared with
usual care (difference in WOMAC-func 3.33, 95% CI
5.88, 0.78, P  0.01; effect size 0.29, 95% CI 0.07, 0.52;
ICC 0.04) (Table 3).
Mean WOMAC-func scores for the Indiv-rehab and Grp-
rehab arms were signiﬁcantly different from usual care
(difference in WOMAC-func: Indiv-rehab 3.53, 95% CI
6.52, 0.55, P  0.04; Grp-rehab 3.16, 95% CI 6.55,
0.12, P  0.04) but not from each other (Indiv-rehab 21.5,
95% CI 19.3, 23.6; Grp-rehab 21.8, 95% CI 19.6, 24.0).
NNT was 7 (95% CI 4, 27; calculation of NNTs from
inversion of the relative risk causes asymmetric 95% CI).
The odds ratio of beneﬁting from rehabilitation compared
with usual care was 1.8 (95% CI 1.2, 2.8).
Effect of withdrawal from trial. Participants who with-
drew from the study between the 6-week and 6-month
assessment had poorer functioning at 6 weeks than those
who remained in the study (mean WOMAC-func 28.0 for
dropouts versus 21.5 for non-dropouts; P  0.013 for test
of the difference). In particular, participants in the usual
care arm who withdrew tended to have worse functioning
at 6 weeks (mean WOMAC-func 34.8 for dropouts versus
24.5 for non-dropouts), whereas participants in Grp-rehab
who withdrew tended to have better functioning (mean
6-week WOMAC-func 14.8 for dropouts versus 20.5 for
non-dropouts). Adjusting for missing 6-week WOMAC-
func scores improved the mean WOMAC-func to 6.45
(95% CI 12.5, 0.44) in Indiv-rehab and 6.14 (95% CI
11.6, 0.70) in Grp-rehab. These point estimates indi-
cate a much greater effect than our primary analysis, with
larger conﬁdence intervals due to the added uncertainty in
the model.
Secondary outcomes. A similar pattern of results was
found for the secondary outcomes (Table 2) and effect
sizes (Table 3): there were differences between rehabilita-
tion and usual care, but no difference between Indiv-rehab
and Grp-rehab.
Preplanned interaction tests. Baseline depression (HADS
depression) had no inﬂuence on treatment effect but was
a signiﬁcant covariate, i.e., high baseline depression was
associated with poor outcome (0.48, P  0.011). Base-
line positive exercise beliefs and conﬁdence in the
ability to exercise (ExBeliefs total) had no inﬂuence on
treatment effect but was a signiﬁcant covariate, i.e., par-
ticipants with higher baseline ExBeliefs total scores had
better functioning at 6 months (0.24, P  0.001). The
same pattern of results was observed with greater conﬁ-
dence in ability to exercise (ExBeliefs self-efﬁcacy), i.e., no
interaction but better functioning at 6 months (0.62, P 
0.001).
Effect of assessor and blinding. Outcomes did not differ
between the 2 assessors. Assessors correctly identiﬁed al-
location in 133 (61%) of 219 participants in the rehabili-
tation groups. WOMAC-func was slightly, but not signiﬁ-
cantly, better in participants whom assessors identiﬁed as
having received rehabilitation (difference in WOMAC-
func 0.60; 95% CI 3.31, 2.11; P  0.66). The effect size
for the subgroup of rehabilitation participants whose allo-
cation was not disclosed was smaller compared with usual
care (difference in WOMAC-func 2.32; 95% CI 5.21,
0.57).
Table 3. Effects of rehabilitation at 6 months (differences between rehabilitation and
usual care, and 95% conﬁdence intervals), adjusting for baseline values of outcomes*
Outcome Effect size
Wald’s
test
P value
Standardized
effect size
Primary outcome
WOMAC-function 3.33 (5.88, 0.78) 0.010 0.29 (0.07, 0.52)
Secondary outcomes
WOMAC-pain 1.01 (1.84, 0.19) 0.016 0.27 (0.05, 0.50)
WOMAC-total 4.59 (8.30, 0.88) 0.015 0.28 (0.05, 0.50)
AFPT, seconds 3.47 (8.13, 1.19) 0.019 0.17 (0.06, 0.41)
ExBeliefs self-efﬁcacy 1.32 (0.58, 2.07) 0.0005 0.41 (0.63, 0.17)
ExBeliefs total 3.58 (2.00, 5.15)  0.0001 0.51 (0.75, 0.28)
HADS anxiety 0.65 (1.28, 0.02) 0.043 0.23 (0.01, 0.46)
HADS depression 0.35 (0.85, 0.16) 0.175 0.16 (0.07, 0.38)
MACTAR 2.20 (0.36, 4.04) 0.019 0.27 (0.50, 0.04)
EQ-5D 0.01 (0.08, 0.05) 0.709 0.09 (0.21, 0.39)
Right QMVC, newtons 7.18 (8.04, 22.4) 0.355 0.13 (0.40, 0.14)
Right QVA, % 6.44 (1.52, 14.4) 0.113 0.20 (0.44, 0.05)
Left QMVC, newtons 7.78 (11.2, 26.8) 0.422 0.10 (0.34, 0.15)
Left QVA, % 5.71 (0.33, 11.1) 0.038 0.26 (0.51, 0.01)
* Differences are expressed in the units in which the outcome was measured. Standardized effect sizes
estimated as Cohen’s d. See Table 1 for deﬁnitions.
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followup, 105 (85%) of 120 Indiv-rehab participants and
59 (55%) of 107 Grp-rehab participants attended 10 of
the 12 sessions.
DISCUSSION
For individuals with chronic knee pain, supplementing
usual primary care with a personalized, progressive re-
habilitation program integrating exercise, education, and
active coping strategies (ESCAPE-knee pain) improved
functioning for up to 6 months after completion of reha-
bilitation, regardless of whether it was delivered to indi-
viduals or small groups of patients. The major strengths of
this trial are its rigor, size, realism, and applicability to
less-controlled clinical contexts (35,36). This is the ﬁrst
pragmatic trial of efﬁcacy for this type of complex health
care intervention for chronic knee pain in primary care. It
was designed, conducted, and analyzed according to a
prespeciﬁed protocol, and had a high followup rate. The
trial enrolled a representative inner-city population with
common comorbidities that primary care physicians en-
counter in daily practice. Although there are no guidelines
for primary care management of chronic knee pain, there
are guidelines for management of OA, but these are poorly
observed for many reasons (12,37). Our participants re-
ported management typical of what has been reported in
primary care (12,38,39): they used few health care re-
sources and had disparate drug regimens with occasional
referral (40,41). The rehabilitation program was carried out
in a typical outpatient department. In addition, although
its general content was similar, the speciﬁc exercise com-
ponents, tailored to address individuals’ needs, varied be-
tween participants and within participants over time as
the exercises were progressed to remain challenging.
These factors reﬂect usual clinical context and practice,
improving the likelihood that the intervention and its ef-
fects will be replicated when performed in clinics (35,36).
Cluster randomized trials that admit individuals have an
increased risk of selection bias and preferential recruit-
ment (26). To avoid this, potential participants were iden-
tiﬁed from primary care practice registers before the prac-
tices were randomized. Potential participants were told
the intervention they would receive before entering the
trial, but because similar numbers of participants ac-
cepted, declined, or withdrew from all arms of the trial,
preferential recruitment is unlikely to have affected the
results. An advantage of the cluster design was that we
could explain unambiguously to potential participants the
intervention they would receive, avoiding the need to
explain randomization procedures. We believe this facili-
tated recruitment and retention to a trial that required a
signiﬁcant commitment of time and effort by participants.
Documenting the reasons for nonparticipation and with-
drawal enables the generalizability of the ﬁndings to be
assessed (35,36).
To standardize the program’s content and delivery, one
experienced physiotherapist delivered the program. This
increases internal validity but might compromise general-
izability if the effectiveness of the intervention were inﬂu-
enced by the therapist’s personal qualities or experience.
However, because ESCAPE-knee pain does not require
specialized training, sophisticated exercises, equipment,
or facilities, other therapists will ﬁnd it easy to replicate.
Recruitment was slightly easier and attendance was bet-
ter in Indiv-rehab than Grp-rehab. This was because indi-
vidual rehabilitation sessions could be arranged at conve-
nient times and missed sessions could be rearranged.
Group sessions were scheduled at inﬂexible times that
were sometimes inconvenient, and missed sessions could
not be rearranged, which is consistent with clinical prac-
tice. Despite attendance differences, group and individual
rehabilitation were equally effective, suggesting that the
number of individual rehabilitation sessions might be re-
duced yet still provide an effective, convenient, ﬂexible
management option.
Blinding interventions that require active participation
is difﬁcult. Our assessors frequently identiﬁed allocation
correctly based on what participants said or did not say,
introducing assessor bias that could have affected out-
come. A preplanned subgroup analysis suggests that un-
blinding was associated with slightly better outcome, but
the difference was not statistically signiﬁcant and the trial
had little power to detect an important difference between
subgroups, therefore this subgroup analysis must be inter-
preted cautiously. Because assessors could not distinguish
between participants who had received individual or
group rehabilitation, comparison of differences between
these arms was not inﬂuenced by unblinding.
The trial did not achieve the target recruitment but nev-
ertheless found signiﬁcant differences between arms. This
is largely because the sample size calculation did not take
into account inclusion of baseline score as a covariate in
the ﬁnal analysis; doing so reduces sample size required
for speciﬁed power almost by half (42), and recruiting
many clusters with a relatively few average number of
patients per practice minimized the design effect (26,27).
Moreover, recent work suggests that 12% may represent
meaningful change (43).
Participants with poor functioning in the usual care arm
may have dropped out of the trial after becoming disillu-
sioned with lack of additional intervention, while partic-
ipants with good functioning in the intervention arm who
experienced only small improvement may have also be-
come disillusioned and dropped out. Conversely, partici-
pants with signiﬁcant functioning deﬁcits who experi-
enced an effective intervention that involved time and
effort on their part may have felt more committed to the
trial. Regardless of the reason for dropping out of the trial,
the differential withdrawal reduced the between-group
differences, underestimating the intervention effect. Tar-
geting individuals likely to beneﬁt the most from the in-
tervention might maximize efﬁcient use of resources.
Our effect sizes for functioning (0.29; 95% CI 0.07, 0.52)
and pain (0.27; 95% CI 0.05, 0.50) were similar to those
found in meta-analyses of exercise (functioning effect size
0.32–0.45, pain effect size 0.39–0.52) (17–19), drug trials
(functioning effect size 0.34, pain effect size 0.66) (21), and
several recent studies of similar patient populations and
interventions (23,44–46). However, most of these studies
measured outcomes immediately after completing pro-
Rehabilitation Program for Chronic Knee Pain 1217longed interventions. The improvements achieved during
ESCAPE-knee pain were attained following a brief, clini-
cally practicable intervention sustained for 6 months; the
number needed to treat was much lower than in drug trials
(47) but without adverse drug events.
Psychological variables and health beliefs are important
determinants of functioning (48). In this study, partici-
pants with positive exercise beliefs who were conﬁdent in
their ability to exercise had better functioning, whereas
those with higher baseline depression had poorer out-
come. People intuitively appreciate that movement is good
for joints but associate movement with pain. In the ab-
sence of appropriate advice they become confused, fright-
ened, and refrain from activities they believe may cause
harm (49). ESCAPE-knee pain was designed to improve
functioning, understanding, and conﬁdence by combining
education, advice, reassurance, and simple coping strate-
gies with the experience of performing supervised func-
tional activities and exercises. Successful performance of
simple exercises and activities without painful exacerba-
tion, coupled with information, advice, and reassurance
from a knowledgeable health care professional, may have
increased participants’ understanding of the importance
and beneﬁt of physical activity, restored conﬁdence in
their abilities, and enabled them to appreciate how they
could help themselves. In this respect the changes in ex-
ercise health beliefs and self-efﬁcacy are notable. How-
ever, speculation about possible mechanisms needs to be
interpreted cautiously until validated by studies speciﬁ-
cally designed to elucidate the mechanisms of the inter-
vention.
As the prevalence of chronic ill health increases, so does
the need for safe, effective, low tech, affordable inter-
ventions that promote self-management and that can be
delivered to large numbers of individuals (24). Such in-
terventions permeate populations more effectively than
complex, expensive interventions that may have large ef-
fects but that few people can access and beneﬁt (35). Con-
sequently, ESCAPE-knee pain could have an impact on
management of knee pain: for the large and growing num-
bers of persons with chronic knee pain, ESCAPE-knee pain
provides health beneﬁts using active coping strategies that
enable individuals to help themselves; for health care pro-
viders, ESCAPE-knee pain provides an effective, relatively
brief, simple alternative or adjunct to medication without
adverse side effects; for policymakers, ESCAPE-knee pain
is an intervention that can be delivered to large numbers of
individuals and that ﬁts with health and social care policy
of increasing physical activity and self-management for
chronic conditions (50).
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